Jeffry Rubin, MD | |
1327 Old York Rd, Abington, PA 19001-3403 | |
(267) 339-3558 | |
(267) 339-3763 |
Full Name | Jeffry Rubin |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1327 Old York Rd, Abington, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922080423 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | MD013471E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jeffry Rubin, MD 833 Chestnut St Ste 520, Philadelphia, PA 19107-4430 Ph: (800) 321-9999 | Jeffry Rubin, MD 1327 Old York Rd, Abington, PA 19001-3403 Ph: (267) 339-3558 |
News Archive
TaiGen Biotechnology Company, Limited today announced that together with its distribution partner, Holding Distribution, it has launched Taigexyn (nemonoxacin) capsules in Taiwan, the first market where Taigexyn is available.
The study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers & Prevention (CEBP) dedicated to best research practices in tobacco science from researchers the world over.
Elsevier Inc., the world's leading publisher of scientific, technical and medical information, announced today that Alcohol has published a special year-end double issue on Fetal Alcohol Spectrum Disorders (FASD). It fills an urgent need to bring the widest possible readership current perspectives on using new research methods to improve identification and diagnosis of offspring at risk for FASD and its associated brain damage and behavioral dysfunction.
In a sweeping analysis assessing the current state of diabetes treatment in the U.S., T1D Exchange researchers conclude that there remains considerable room for improving treatment outcomes in type 1 diabetes across all age groups, but especially for adolescents and young adults.
If you want to increase your chances of living longer, taking cholesterol drugs is an easy way to do it. That's the message from a Harvard study of 4,162 people hospitalized in 350 places in eight countries. It is the first research to show that intense lowering of cholesterol results in a major reduction in deaths and severe heart attacks.
› Verified 6 days ago
Megan Diane Jiras, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1327 Old York Rd, Abington, PA 19001 Phone: 800-321-9999 |